Compound Detail
CHEMBL5407719
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5407719 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UJTUQUMJIQYKTQ-CMDGGOBGSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
315.8
MW (Da)
3.64
ALogP
3
HBA
0
HBD
50.5
PSA (Ų)
0.80
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.64
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MGC-803 | IC50 | = | 2271.0 | nM | 5.64 | Antiproliferative activity against human MGC-803 cells assessed as inhibition of... | 36162214 |
| HepG2 | IC50 | = | 2705.0 | nM | 5.57 | Antiproliferative activity against human HepG2 cells assessed as inhibition of c... | 36162214 |
| MCF7 | IC50 | = | 3105.0 | nM | 5.51 | Antiproliferative activity against human MCF7 cells assessed as inhibition of ce... | 36162214 |
| A549 | IC50 | = | 3566.0 | nM | 5.45 | Antiproliferative activity against human A549 cells assessed as inhibition of ce... | 36162214 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36162214 | 10.1016/j.ejmech.2022.114738 | A549 | 1 |
| 36162214 | 10.1016/j.ejmech.2022.114738 | HepG2 | 1 |
| 36162214 | 10.1016/j.ejmech.2022.114738 | HeLa | 1 |
| 36162214 | 10.1016/j.ejmech.2022.114738 | MCF7 | 1 |
| 36162214 | 10.1016/j.ejmech.2022.114738 | MGC-803 | 1 |
| 36162214 | 10.1016/j.ejmech.2022.114738 | U-937 | 1 |
Data from ChEMBL 36 via Core Engine